CHANGE THE NAME FROM ALKERMES TO SUNOVION!

Quote






Anonymous said:
Sunomes would be a good name! If your worked in the past for one of the interviewing managers, you are a shoe in. A lot of people went on "fake interviews", because HR wanted several names contending for a position. Talked about a rigged game!
Click to expand...

GET USED TO IT, IT HAS BEEN LIKE THAT FOR THE LAST 5 YEARS. ALL THE INTERVIEWS ARE RIGGED. EVERY COMPANY. YOU ARE COMPETTING AGAINST FRIENDS, FORMER EMPLOYEES, FORMER THIS AND THAT AND EVEN IF THEY ARE SHIT, THEY WILL GET THE JOB BEFORE YOU DO
 












Anonymous said:
they will bring in one LAI Otsuka or Lundbeck Rep to help steer them with product and current inside knowledge and the intricacies of selling this LAI molecule. The rest were pre chosen from Sunovian. No one ever really had a chance.
Click to expand...

Face it, there will be more Otsuka than Sunovion on board. Many Sunovion's wanted the positions and interviewed including certain ASDs, RBMs, and Reps. Some were considered front runners until the interviews and the competition they faced. Many became backups and most weren't in consideration any more. A good number of Sunovions, the best ones, will join Alkermes but no where near as many as Sunovion's think. We don't compete with pill pushers so it's best to let it go and move on. Once it plays out all you trolls can go back to your board and continue your miserable fate over the next two years as Latuda LOE strategy begins.
 












Given the history of pipeline setbacks, a negative decision on aripiprazole lauroxil will be a huge setback for the company. Earlier in the year, Alkermes discontinued the development of a mid-stage candidate, ALKS 7106.”
 






Anonymous said:
Given the history of pipeline setbacks, a negative decision on aripiprazole lauroxil will be a huge setback for the company. Earlier in the year, Alkermes discontinued the development of a mid-stage candidate, ALKS 7106.”
Click to expand...

Speculation on fda decisions is about as assanine as saying that Sunovion will get another product in the bag to offset the Lat LOE.
 






Anonymous said:
Given the history of pipeline setbacks, a negative decision on aripiprazole lauroxil will be a huge setback for the company. Earlier in the year, Alkermes discontinued the development of a mid-stage candidate, ALKS 7106.”
Click to expand...

Alkermes Plc (NASDAQ:ALKS) was downgraded by Zacks from a “buy” rating to a “hold” rating in a research note issued on Monday.
 


















Anonymous said:
Inspiring words from the Sunovion ASD in the West or the G-man himself. You could be a rep that didn't make the cut too.
Click to expand...

Guessed wrong dummy. I work here and see that other than maybe one person everyone from that company sucks. THe HO people think they have more experience than they do and it shows. And the sales people are just arrogant. And it's like some sick brotherhood too. Weird
 






Anonymous said:
Guessed wrong dummy. I work here and see that other than maybe one person everyone from that company sucks. THe HO people think they have more experience than they do and it shows. And the sales people are just arrogant. And it's like some sick brotherhood too. Weird
Click to expand...

Riiigghhhtttt! You have worked with all of them and can judge the quality of their work. Stay miserable my dumb friend and when you see who are the top managers let me be the first to say "scoreboard"! Too bad bottom feeding, mouth breathers like you are here. Hope you will stay in Indiana or the NE where you belong. Hope that helps
 






Top Bottom
Back
Quote